This review highlights the pivotal role of inflammation-related molecules, including CXCL9, CXCL10, VCAM-1, TNF-α, IL-1β, IL-6, and IL-17A, in the pathogenesis and progression of MASLD and SAH. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.